Stocks
iShares Biotechnology ETFIBB
NASDAQHealthcareBiotechnology$165.51-0.43%
An exchange-traded fund that tracks the Nasdaq Biotechnology Index, providing exposure to a broad basket of U.S.-listed biotechnology and pharmaceutical development companies. The fund holds large and mid-cap biotech firms involved in drug discovery, clinical research, and commercialization. Investo...
Market Cap: $8.0B52W Range: $107.43 – $179.64
Congressional Interest in iShares Biotechnology ETF (IBB)
6 members of Congress have disclosed 8 trades in iShares Biotechnology ETF (IBB), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 5 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
8
Unique Politicians
6
Buys
3
Sells
5
Who in Congress Is Trading IBB?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-02-23 | DAVID P. JOYCE | sell | $1K – $15K |
| 2017-02-17 | DAVID P. JOYCE | sell | $1K – $15K |